Cargando…
A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452495/ https://www.ncbi.nlm.nih.gov/pubmed/30997070 http://dx.doi.org/10.1002/ccr3.2056 |
_version_ | 1783409300020920320 |
---|---|
author | Nakamura, Naohiko Kinami, Shinichi Fujii, Yoritaka Miura, Seiko Fujita, Jun Kaida, Daisuke Tomita, Yasuto Miyata, Takashi Fujita, Hideto Ueda, Nobuhiko Kosaka, Takeo |
author_facet | Nakamura, Naohiko Kinami, Shinichi Fujii, Yoritaka Miura, Seiko Fujita, Jun Kaida, Daisuke Tomita, Yasuto Miyata, Takashi Fujita, Hideto Ueda, Nobuhiko Kosaka, Takeo |
author_sort | Nakamura, Naohiko |
collection | PubMed |
description | When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients. |
format | Online Article Text |
id | pubmed-6452495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64524952019-04-17 A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases Nakamura, Naohiko Kinami, Shinichi Fujii, Yoritaka Miura, Seiko Fujita, Jun Kaida, Daisuke Tomita, Yasuto Miyata, Takashi Fujita, Hideto Ueda, Nobuhiko Kosaka, Takeo Clin Case Rep Case Reports When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients. John Wiley and Sons Inc. 2019-02-26 /pmc/articles/PMC6452495/ /pubmed/30997070 http://dx.doi.org/10.1002/ccr3.2056 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Nakamura, Naohiko Kinami, Shinichi Fujii, Yoritaka Miura, Seiko Fujita, Jun Kaida, Daisuke Tomita, Yasuto Miyata, Takashi Fujita, Hideto Ueda, Nobuhiko Kosaka, Takeo A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases |
title | A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases |
title_full | A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases |
title_fullStr | A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases |
title_full_unstemmed | A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases |
title_short | A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases |
title_sort | remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: a report of two cases |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452495/ https://www.ncbi.nlm.nih.gov/pubmed/30997070 http://dx.doi.org/10.1002/ccr3.2056 |
work_keys_str_mv | AT nakamuranaohiko aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT kinamishinichi aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT fujiiyoritaka aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT miuraseiko aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT fujitajun aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT kaidadaisuke aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT tomitayasuto aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT miyatatakashi aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT fujitahideto aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT uedanobuhiko aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT kosakatakeo aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT nakamuranaohiko remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT kinamishinichi remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT fujiiyoritaka remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT miuraseiko remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT fujitajun remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT kaidadaisuke remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT tomitayasuto remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT miyatatakashi remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT fujitahideto remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT uedanobuhiko remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases AT kosakatakeo remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases |